Broken redirects

Jump to navigation Jump to search

The following redirects link to non-existent pages:

Showing below up to 50 results in range #2,271 to #2,320.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty 5 (ARMYDA-5) Presented Today at TCT 2007 → Special:Badtitle/NS100:Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty 5 (ARMYDA-5) Presented Today at TCT 2007
  2. Antiplatelets: Clopidogrel-to-Ticlopidine Crossover Study Demonstrates Drug Specific Resistance → Special:Badtitle/NS100:Antiplatelets: Clopidogrel-to-Ticlopidine Crossover Study Demonstrates Drug Specific Resistance
  3. Anxious individuals are at risk for heart attacks → Special:Badtitle/NS100:Anxious individuals are at risk for heart attacks
  4. Apixaban causes increased bleeding, but reduced ischemic events in patients with recent acute coronary syndrome: Results of the APPRAISE-1 Trial → Special:Badtitle/NS100:Apixaban causes increased bleeding, but reduced ischemic events in patients with recent acute coronary syndrome: Results of the APPRAISE-1 Trial
  5. Arginine metabolite found to predict mortality in patients with cardiogenic shock → Special:Badtitle/NS100:Arginine metabolite found to predict mortality in patients with cardiogenic shock
  6. Aspiration before Primary PCI Improves Outcomes: Results of EXPIRA and EXPORT → Special:Badtitle/NS100:Aspiration before Primary PCI Improves Outcomes: Results of EXPIRA and EXPORT
  7. Atherosclerosis: Study links atherosclerosis progression to traffic exposure → Special:Badtitle/NS100:Atherosclerosis: Study links atherosclerosis progression to traffic exposure
  8. Atrial tachyarrhythmia burden ≥5.5h in a day doubles the risk for thromboembolism in the TRENDS study → Special:Badtitle/NS100:Atrial tachyarrhythmia burden ≥5.5h in a day doubles the risk for thromboembolism in the TRENDS study
  9. Automated External Defibrillators offer no benefit in cardiac arrests that occur at home in the HAT trial → Special:Badtitle/NS100:Automated External Defibrillators offer no benefit in cardiac arrests that occur at home in the HAT trial
  10. BEAUTIFUL study fails to meet primary endpoint but demonstrates that heart rates can safely be reduced with Ivabradine → Special:Badtitle/NS100:BEAUTIFUL study fails to meet primary endpoint but demonstrates that heart rates can safely be reduced with Ivabradine
  11. Better to be a pear than an apple: new prospective look at associations between fat distribution and coronary heart disease → Special:Badtitle/NS100:Better to be a pear than an apple: new prospective look at associations between fat distribution and coronary heart disease
  12. Biolimus Eluting Stents Shown to be as Safe and Effective as Sirolimus Eluting Stents in Everyday Clinical Practice: Results from the LEADERS Trial → Special:Badtitle/NS100:Biolimus Eluting Stents Shown to be as Safe and Effective as Sirolimus Eluting Stents in Everyday Clinical Practice: Results from the LEADERS Trial
  13. Bivalirudin during primary PCI reduces major bleeding and adverse events at 30 days in the HORIZONS-AMI trial → Special:Badtitle/NS100:Bivalirudin during primary PCI reduces major bleeding and adverse events at 30 days in the HORIZONS-AMI trial
  14. Bivalirudin is no better than heparin in patients pretreated with clopidogrel undergoing PCI: Results from the ISAR-REACT-3 trial → Special:Badtitle/NS100:Bivalirudin is no better than heparin in patients pretreated with clopidogrel undergoing PCI: Results from the ISAR-REACT-3 trial
  15. Cardiac Resynchronization Therapy and Single Center Experience Links Survival → Special:Badtitle/NS100:Cardiac Resynchronization Therapy and Single Center Experience Links Survival
  16. Cardiac arrest during weekends and nights is associated with poor outcomes → Special:Badtitle/NS100:Cardiac arrest during weekends and nights is associated with poor outcomes
  17. Cardiogenic Shock: New Treatment Options with Percutaneous Left Ventricular Assist Devices? → Special:Badtitle/NS100:Cardiogenic Shock: New Treatment Options with Percutaneous Left Ventricular Assist Devices?
  18. Cardiologists’ Use of Pulmonary Artery Catheter Information in CCU Treatment Decisions → Special:Badtitle/NS100:Cardiologists’ Use of Pulmonary Artery Catheter Information in CCU Treatment Decisions
  19. Cardiovascular risk increases with incremental doses of celecoxib → Special:Badtitle/NS100:Cardiovascular risk increases with incremental doses of celecoxib
  20. Changes in Residents’ Hours of Work Not Generally Reflected in Improved Outcomes → Special:Badtitle/NS100:Changes in Residents’ Hours of Work Not Generally Reflected in Improved Outcomes
  21. Clinical Research Organizations (CROs), Academic Research Organizations (AROs), or Industry: Who’s best for clinical research → Special:Badtitle/NS100:Clinical Research Organizations (CROs), Academic Research Organizations (AROs), or Industry: Who’s best for clinical research
  22. Clinical data support the non-inferiority of continuous chest compressions compared with conventional cardiopulmonary resuscitation → Special:Badtitle/NS100:Clinical data support the non-inferiority of continuous chest compressions compared with conventional cardiopulmonary resuscitation
  23. Clot retrieval from the coronary arteries during primary angioplasty improves myocardial perfusion and clinical outcomes → Special:Badtitle/NS100:Clot retrieval from the coronary arteries during primary angioplasty improves myocardial perfusion and clinical outcomes
  24. CoStar Drug Eluting Stent is not Non-inferior to TAXUS Drug Eluting Stents → Special:Badtitle/NS100:CoStar Drug Eluting Stent is not Non-inferior to TAXUS Drug Eluting Stents
  25. Cocoa Containing Flavanols might be Beneficial in Diabetic Patients with Vascular Dysfunction → Special:Badtitle/NS100:Cocoa Containing Flavanols might be Beneficial in Diabetic Patients with Vascular Dysfunction
  26. Coronary Calcium Coverage Score is Associated with an Increase in the Risk of Coronary Artery Disease → Special:Badtitle/NS100:Coronary Calcium Coverage Score is Associated with an Increase in the Risk of Coronary Artery Disease
  27. Coronary heart disease mortality in young women makes the headline news → Special:Badtitle/NS100:Coronary heart disease mortality in young women makes the headline news
  28. Culotte is better than crush for bifurcation lesions: Results from the Nordic Stent Technique study → Special:Badtitle/NS100:Culotte is better than crush for bifurcation lesions: Results from the Nordic Stent Technique study
  29. Cyclosporine Reduces Reperfusion Injury and Infarct Size Following Acute Myocardial Infarction → Special:Badtitle/NS100:Cyclosporine Reduces Reperfusion Injury and Infarct Size Following Acute Myocardial Infarction
  30. Darapladib A Direct Lipoprotein Associated Phospholipase A2 Inhibitor Reduces Necrotic Core but not Plaque Deformability → Special:Badtitle/NS100:Darapladib A Direct Lipoprotein Associated Phospholipase A2 Inhibitor Reduces Necrotic Core but not Plaque Deformability
  31. Data from ADHERE: BNP and Troponin are independent predictors of in-hospital mortality in patients with decompensated heart failure → Special:Badtitle/NS100:Data from ADHERE: BNP and Troponin are independent predictors of in-hospital mortality in patients with decompensated heart failure
  32. Defribillators: Systematic Review of ICDs for Adults with LV Systolic Dysfunction → Special:Badtitle/NS100:Defribillators: Systematic Review of ICDs for Adults with LV Systolic Dysfunction
  33. Diabetes Care Makes an "ADVANCE" with Better Blood Pressure Control → Special:Badtitle/NS100:Diabetes Care Makes an "ADVANCE" with Better Blood Pressure Control
  34. Diagnosing Heart Failure in the Emergency Department → Special:Badtitle/NS100:Diagnosing Heart Failure in the Emergency Department
  35. Door-to-Ballon Time less than 90 Minutes is Achievable and Sustainable: the Geisinger experience. August 12, 2007 → Special:Badtitle/NS100:Door-to-Ballon Time less than 90 Minutes is Achievable and Sustainable: the Geisinger experience. August 12, 2007
  36. Dronedarone (Multaq®) a Promising New Drug for the Management of Patients with Atrial Fibrillation or Flutter → Special:Badtitle/NS100:Dronedarone (Multaq®) a Promising New Drug for the Management of Patients with Atrial Fibrillation or Flutter
  37. Drug-Eluting Stents: Meta-analysis Demonstrates Superior Clinical Performance of Sirolimus-eluting Stents (SES) Over Bare-metal Stents (BMS) and Paclitaxel-eluting Stents (PES) → Special:Badtitle/NS100:Drug-Eluting Stents: Meta-analysis Demonstrates Superior Clinical Performance of Sirolimus-eluting Stents (SES) Over Bare-metal Stents (BMS) and Paclitaxel-eluting Stents (PES)
  38. Drug Eluting Stents Continue to Demonstrate Superiority over Bare Metal Stents in Reducing the Need for Repeat Revascularization → Special:Badtitle/NS100:Drug Eluting Stents Continue to Demonstrate Superiority over Bare Metal Stents in Reducing the Need for Repeat Revascularization
  39. Drug Eluting Stents are Associated with Reduced Mortality Compared with Bare Metal Stents → Special:Badtitle/NS100:Drug Eluting Stents are Associated with Reduced Mortality Compared with Bare Metal Stents
  40. Drug eluting stents: GRACE Analysis Shows Five Times Higher Mortality Rate Between Six Months and Two Years Among Patients Receivng DES → Special:Badtitle/NS100:Drug eluting stents: GRACE Analysis Shows Five Times Higher Mortality Rate Between Six Months and Two Years Among Patients Receivng DES
  41. Drug eluting stents are associated with reduced mortality in patients with myocardial infarction at two years → Special:Badtitle/NS100:Drug eluting stents are associated with reduced mortality in patients with myocardial infarction at two years
  42. Dual therapy better than monotherapy to treat hypertension in the ACCOMPLISH trial → Special:Badtitle/NS100:Dual therapy better than monotherapy to treat hypertension in the ACCOMPLISH trial
  43. Duke Research Teams Provide Insight into Small Vessels, Stored Blood, and Nitric Oxide → Special:Badtitle/NS100:Duke Research Teams Provide Insight into Small Vessels, Stored Blood, and Nitric Oxide
  44. Early Transfer of AMI Patients for PCI improves cardiovascular outcomes in the TRANSFER-AMI study → Special:Badtitle/NS100:Early Transfer of AMI Patients for PCI improves cardiovascular outcomes in the TRANSFER-AMI study
  45. Elevated Plasma Fibrinogen Levels among Diabetics and Increased BMI are Associated with Reduced Platelet Inhibition with Clopidogrel → Special:Badtitle/NS100:Elevated Plasma Fibrinogen Levels among Diabetics and Increased BMI are Associated with Reduced Platelet Inhibition with Clopidogrel
  46. Elevated microalbuminuria within the “normal-range” predicts mortality in patients with stable angina → Special:Badtitle/NS100:Elevated microalbuminuria within the “normal-range” predicts mortality in patients with stable angina
  47. Emergency Medical Services Remain Underutilized in STEMI Patients → Special:Badtitle/NS100:Emergency Medical Services Remain Underutilized in STEMI Patients
  48. Eptifibatide: Result of EVA-AMI Trial Released → Special:Badtitle/NS100:Eptifibatide: Result of EVA-AMI Trial Released
  49. Eptifibatide: Results of BRIEF-PCI Trial Released → Special:Badtitle/NS100:Eptifibatide: Results of BRIEF-PCI Trial Released
  50. Erectile dysfunction is associated with adverse cardiovascular events among diabetic patients → Special:Badtitle/NS100:Erectile dysfunction is associated with adverse cardiovascular events among diabetic patients

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://www.wikidoc.org/index.php/Special:BrokenRedirects"